These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16928267)

  • 21. Quality of life and its correlates among heroin users in Taiwan.
    Yen CN; Wang CS; Wang TY; Chen HF; Chang HC
    Kaohsiung J Med Sci; 2011 May; 27(5):177-83. PubMed ID: 21527184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral health status of heroin users in a rehabilitation centre in Hubei province, China.
    Du M; Bedi R; Guo L; Champion J; Fan M; Holt R
    Community Dent Health; 2001 Jun; 18(2):94-8. PubMed ID: 11461065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social status, health status and therapy response in heroin addicts.
    Abalkhail BA
    East Mediterr Health J; 2001 May; 7(3):465-72. PubMed ID: 12690768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
    Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 10-year follow-up study on the health status of heroin addicts based on official registers.
    Sánchez-Carbonell X; Vilaregut A
    Addiction; 2001 Dec; 96(12):1777-86. PubMed ID: 11784470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression among regular heroin users: the influence of gender.
    Sordo L; Chahua M; Bravo MJ; Barrio G; Brugal MT; Domingo-Salvany A; Molist G; De la Fuente L;
    Addict Behav; 2012 Jan; 37(1):148-52. PubMed ID: 21968230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for controlled heroin use? Low levels of negative health and social outcomes among non-treatment heroin users in Glasgow (Scotland).
    Shewan D; Dalgarno P
    Br J Health Psychol; 2005 Feb; 10(Pt 1):33-48. PubMed ID: 15826332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study.
    Salamina G; Diecidue R; Vigna-Taglianti F; Jarre P; Schifano P; Bargagli AM; Davoli M; Amato L; Perucci CA; Faggiano F;
    Subst Use Misuse; 2010 Oct; 45(12):2076-92. PubMed ID: 20438317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone treatment in clinical practice in Italy: need for improvement.
    Schifano P; Bargagli AM; Belleudi V; Amato L; Davoli M; Diecidue R; Versino E; Vigna-Taglianti F; Faggiano F; Perucci CA
    Eur Addict Res; 2006; 12(3):121-7. PubMed ID: 16778432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence.
    Origer A; Schmit JC
    J Epidemiol Community Health; 2012 Jan; 66(1):64-8. PubMed ID: 20889592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.